Molecules 2010, 15(5), 3281-3294; doi:10.3390/molecules15053281
Review

4D-QSAR: Perspectives in Drug Design

Received: 1 March 2010; in revised form: 30 March 2010 / Accepted: 6 April 2010 / Published: 4 May 2010
(This article belongs to the Special Issue Structure-Based Drug Design)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Drug design is a process driven by innovation and technological breakthroughs involving a combination of advanced experimental and computational methods. A broad variety of medicinal chemistry approaches can be used for the identification of hits, generation of leads, as well as to accelerate the optimization of leads into drug candidates. The quantitative structure–activity relationship (QSAR) formalisms are among the most important strategies that can be applied for the successful design new molecules. This review provides a comprehensive review on the evolution and current status of 4D-QSAR, highlighting present challenges and new opportunities in drug design.
Keywords: QSAR; 4D-QSAR; Structure-based QSAR; Drug Design
PDF Full-text Download PDF Full-Text [2711 KB, uploaded 18 June 2014 19:32 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Andrade, C.H.; Pasqualoto, K.F.M.; Ferreira, E.I.; Hopfinger, A.J. 4D-QSAR: Perspectives in Drug Design. Molecules 2010, 15, 3281-3294.

AMA Style

Andrade CH, Pasqualoto KFM, Ferreira EI, Hopfinger AJ. 4D-QSAR: Perspectives in Drug Design. Molecules. 2010; 15(5):3281-3294.

Chicago/Turabian Style

Andrade, Carolina H.; Pasqualoto, Kerly F. M.; Ferreira, Elizabeth I.; Hopfinger, Anton J. 2010. "4D-QSAR: Perspectives in Drug Design." Molecules 15, no. 5: 3281-3294.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert